SBI Healthcare Opportunities Fund vs UTI Innovation Fund
Direct Plan, Growth option · Data as on 30-10-2026
SBI Healthcare Opportunities Fund is a Thematic fund and UTI Innovation Fund is a Thematic fund. In the 3 years to 30-10-2026, SBI Healthcare Opportunities Fund (Direct) returned 24.6% a year and UTI Innovation Fund (Direct) returned 3.9% a year. SBI Healthcare Opportunities Fund charges 1.01% a year and UTI Innovation Fund 1.26% (Direct plans). Their portfolios overlap 6.9%: they hold 2 of the same securities.
SBI Healthcare Opportunities Fund
Thematic
- 3 year return
- 24.6%
- Expense ratio
- 1.01%
- NAV
- ₹588.16
Which is better, SBI Healthcare Opportunities or UTI Innovation? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- SBI Healthcare Opportunities returned more over 3 years: 24.6% a year against 3.9%.
- SBI Healthcare Opportunities returned more over 1 year: 17.1% against −9.5%.
- SBI Healthcare Opportunities costs less: 1.01% a year against 1.26% (Direct plans).
- SBI Healthcare Opportunities swung less over 3 years: a standard deviation of 13.1% a year against 18.1%.
- SBI Healthcare Opportunities fell less in its worst fall since 18-10-2023: −13.5% against −31.5%.
- SBI Healthcare Opportunities holds more in large companies: 32.3% of the fund in large caps against 13.7%.
- SBI Healthcare Opportunities is the larger fund: ₹5,870 Cr against ₹768 Cr.
- Their portfolios overlap 6.9%: 2 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | SBI Healthcare Opportunities Fund | UTI Innovation Fund |
|---|---|---|
| Fund house | SBI Mutual Fund | UTI Mutual Fund |
| Category | Thematic | Thematic |
| AUM | ₹5,870 Cr (30-09-2026) | ₹768 Cr (30-09-2026) |
| NAV | ₹588.16 (Direct) | ₹11.19 (Direct) |
| Expense ratio (Direct) | 1.01% | 1.26% |
| Expense ratio (Regular) | 1.99% | 2.43% |
| Riskometer | Not available | Very High |
| Benchmark | Not available | Nifty 500 TRI |
| Launch date | Not available | 13-10-2023 |
| Minimum investment | Not available | REGULAR PLAN-GROWTH:5000 , DIRECT PLAN-GROWTH:5000, REGULAR PLAN-PAYOUT OF IDCW:5000, DIRECT PLAN-PAYOUT OF IDCW:5000 |
| Lock in | Not available | None |
| Fund managers | Not available | Nitin Jain FM 1 |
| Exit load | Not available | 1% if redeemed/switched out within 12 months from the date of allotment, Nil thereafter. |
SBI Healthcare Opportunities vs UTI Innovation: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund (Direct) | +0.31% | −0.59% | +16.00% | +17.12% | +24.60% | +19.22% | +14.72% |
| UTI Innovation Fund (Direct) | −1.91% | −4.29% | +3.52% | −9.51% | +3.91% | -- | -- |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | -- | -- |
Category average: the average of the 235 Thematic funds, same plan type.
SBI Healthcare Opportunities vs UTI Innovation: Year-wise Returns
| Year | SBI Healthcare OpportunitiesSBI Healthcare Opportunities | UTI InnovationUTI Innovation |
|---|---|---|
| 2026to date | +21.31% | −5.63% |
| 2025 | −2.50% | −6.47% |
| 2024 | +43.75% | +20.12% |
| 2023 | +39.72% | -- |
| 2022 | −5.01% | -- |
| 2021 | +21.48% | -- |
SBI Healthcare Opportunities vs UTI Innovation: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of SBI Healthcare Opportunities Fund
Rolling returns
Every 1-year holding period, 507 of them, one for each trading day from 18-10-2024 to 30-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
SBI Healthcare Opportunities Fund (Direct)
UTI Innovation Fund (Direct)
BSE Healthcare TRI
to
Dec 2024Apr 2024
to
Apr 2025Aug 2024
to
Aug 2025Dec 2024
to
Dec 2025May 2025
to
May 2026Aug 2025
to
Aug 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities | 6.7 | 13.6 | 12.8 | 14.6 | 14.2 | 21.1 | 17.0 | 17.1% | 15.9% | −3.3% | 59.2% | 79% |
| UTI Innovation | 59.0 | 21.0 | 6.8 | 3.0 | 3.2 | 5.8 | 1.2 | 0.6% | −1.3% | −13.8% | 28.5% | 0% |
| BSE Healthcare TRI | 8.1 | 16.4 | 14.4 | 21.1 | 17.4 | 8.3 | 14.4 | 15.3% | 12.5% | −3.7% | 61.9% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is BSE Healthcare TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 18-10-2023. Past returns do not promise future returns.
SBI Healthcare Opportunities vs UTI Innovation: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 03-10-2023 to 30-10-2026: 37 instalments, ₹3,70,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| SBI Healthcare OpportunitiesSBI Healthcare Opportunities Fund (Direct) | ₹3,70,000 | ₹4,84,796 | ₹1,14,796 | 17.9% |
| UTI InnovationUTI Innovation Fund (Direct) | ₹3,70,000 | ₹3,67,249 | −₹2,751 | −0.5% |
SBI Healthcare OpportunitiesSBI Healthcare Opportunities Fund (Direct)
UTI InnovationUTI Innovation Fund (Direct)
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
SBI Healthcare Opportunities vs UTI Innovation: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | SBI Healthcare Opportunities Fund (Direct) | UTI Innovation Fund (Direct) |
|---|---|---|
| Return (CAGR) | +17.12% | −9.51% |
| Standard deviation | 13.36% | 19.38% |
| Sharpe ratio | 0.89 | -0.76 |
| Sortino ratio | 1.33 | -1.02 |
| Maximum drawdown | −10.3% (23-10-2026) | −25.7% (23-03-2026) |
| Beta | 0.93 | 1.13 |
| Alpha | +5.25% | −0.48% |
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | SBI Healthcare Opportunities Fund (Direct) | UTI Innovation Fund (Direct) |
|---|---|---|
| Return (CAGR) | +24.60% | +3.91% |
| Standard deviation | 13.07% | 18.10% |
| Sharpe ratio | 1.42 | -0.12 |
| Sortino ratio | 2.03 | -0.16 |
| Maximum drawdown | −13.5% (28-02-2025) | −31.5% (23-03-2026) |
| Beta | 0.88 | 1.05 |
| Alpha | +3.61% | −6.51% |
From daily NAVs, 30-10-2023 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | SBI Healthcare Opportunities Fund (Direct) | UTI Innovation Fund (Direct) |
|---|---|---|
| Return (CAGR) | +17.93% | +3.71% |
| Standard deviation | 15.96% | 18.01% |
| Sharpe ratio | 0.74 | -0.13 |
| Sortino ratio | 1.05 | -0.18 |
| Maximum drawdown | −30.5% (23-03-2020) | −31.5% (23-03-2026) |
| Beta | 0.91 | 1.04 |
| Alpha | +3.97% | −5.44% |
From daily NAVs, 02-01-2013 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
SBI Healthcare Opportunities Fund (Direct)
UTI Innovation Fund (Direct)
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund (Direct) | −13.5% | 07-01-2025 | 28-02-2025 | 17-07-2025 | 5 months | −3.8% |
| UTI Innovation Fund (Direct) | −31.5% | 23-09-2024 | 23-03-2026 | Not yet | -- | −16.6% |
| BSE Healthcare TRI | −16.2% | 02-01-2025 | 28-02-2025 | 29-07-2025 | 5 months | −3.8% |
From daily values since 18-10-2023, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
SBI Healthcare Opportunities Fund (Direct)
UTI Innovation Fund (Direct)
BSE Healthcare TRI
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 3-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
SBI Healthcare Opportunities Fund (Direct)
UTI Innovation Fund (Direct)
BSE Healthcare TRI
Against BSE Healthcare TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| SBI Healthcare Opportunities Fund (Direct) | 97% | 83% | 3.96% |
| UTI Innovation Fund (Direct) | 73% | 149% | 14.62% |
From month-end values since 18-10-2023. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
SBI Healthcare Opportunities vs UTI Innovation: Portfolio Overlap
From each fund's latest monthly portfolio: SBI Healthcare Opportunities Fund, September 2026; UTI Innovation Fund, September 2026
Holdings in common
- Overlap
- 6.9%
- Held by both
- 2
- Only in SBI Healthcare Opportunities
- 34
- Only in UTI Innovation
- 30
| Security | % of SBI Healthcare Opportunities | % of UTI Innovation |
|---|---|---|
| Acutaas Chemicals Ltd. | 5.03% | 4.92% |
| Divi's Laboratories Ltd. | 7.91% | 2.02% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 6.9% means 6.9% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in SBI Healthcare Opportunities Fund
| Security | % of fund |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.14% |
| Apollo Hospitals Enterprise Ltd. | 4.45% |
| Torrent Pharmaceuticals Ltd. | 4.42% |
| Cipla Ltd. | 4.40% |
| Laurus Labs Ltd. | 4.05% |
Largest holdings only in UTI Innovation Fund
| Security | % of fund |
|---|---|
| EQ - ETERNAL LIMITED | 9.39% |
| EQ - INFO-EDGE (INDIA) LTD. | 9.07% |
| EQ - FSN E-COMMERCE VENTURES(NYKAA) | 6.15% |
| EQ - AFFLE 3I LIMITED | 5.74% |
| EQ - ONE 97 COMMUNICATIONS LTD | 4.83% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | SBI Healthcare Opportunities | UTI Innovation |
|---|---|---|
| Equity | 95.5% | 96.2% |
| Debt | 0.1% | 0.0% |
| Cash and others | 4.4% | 3.8% |
Market cap of stocks
| Market cap | SBI Healthcare Opportunities | UTI Innovation |
|---|---|---|
| Large Cap | 32.3% | 13.7% |
| Mid Cap | 25.7% | 32.7% |
| Small Cap | 35.4% | 47.6% |
| Not on AMFI's list | 2.2% | 2.2% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | SBI Healthcare Opportunities | UTI Innovation |
|---|---|---|
| Pharmaceuticals & Biotechnology | 63.1% | 6.9% |
| Retailing | 0.0% | 30.1% |
| Healthcare Services | 25.6% | 0.0% |
| IT - Software | 0.0% | 15.8% |
| Financial Technology (Fintech) | 0.0% | 7.9% |
| IT - Services | 0.0% | 7.0% |
| Chemicals & Petrochemicals | 5.0% | 2.9% |
| Electrical Equipment | 0.0% | 4.7% |
| Healthcare Equipment & Supplies | 1.8% | 0.0% |
The six largest sectors of each fund's stocks, % of the fund.
SBI Healthcare Opportunities vs UTI Innovation: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | SBI Healthcare Opportunities Fund | UTI Innovation Fund |
|---|---|---|
| Total expense ratio (Direct) | 1.01% | 1.26% |
| Base expense ratio (Direct) | 0.74% | 0.96% |
| Total expense ratio (Regular) | 1.99% | 2.43% |
| Base expense ratio (Regular) | 1.58% | 2.04% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare SBI Healthcare Opportunities with
SBI Healthcare Opportunities Fund vs UTI Innovation Fund: Frequently Asked Questions
What is the difference between SBI Healthcare Opportunities Fund and UTI Innovation Fund?
SBI Healthcare Opportunities Fund is a Thematic fund, UTI Innovation Fund is a Thematic fund, run by SBI Mutual Fund and UTI Mutual Fund. Their portfolios overlap 6.9%. SBI Healthcare Opportunities Fund charges 1.01% a year and UTI Innovation Fund 1.26%.
Which has given higher returns, SBI Healthcare Opportunities Fund or UTI Innovation Fund?
Over 1 year: SBI Healthcare Opportunities Fund +17.12%, UTI Innovation Fund −9.51%. Over 3 years: SBI Healthcare Opportunities Fund +24.60% a year, UTI Innovation Fund +3.91% a year. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, SBI Healthcare Opportunities Fund or UTI Innovation Fund?
SBI Healthcare Opportunities Fund charges less: 1.01% a year against 1.26%. These are the Direct plans' total expense ratios reported to AMFI.
How much do SBI Healthcare Opportunities Fund and UTI Innovation Fund overlap?
6.9%. They hold 2 of the same securities, the largest shared ones being ACUTAAS, DIVISLAB. From each fund's latest monthly portfolio.
Which is better for SIP, SBI Healthcare Opportunities Fund or UTI Innovation Fund?
Over the last 3 years, a monthly SIP of ₹10,000 from 03-10-2023 to 30-10-2026 grew to ₹4,84,796 in SBI Healthcare Opportunities Fund (XIRR 17.9% a year) and ₹3,67,249 in UTI Innovation Fund (XIRR -0.5% a year). Both received 37 instalments. Past returns do not promise future returns.
Can I invest in both SBI Healthcare Opportunities Fund and UTI Innovation Fund?
Yes. 6.9% of each fund's money sits in the same holdings, so the two hold mostly different investments.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.